首页> 美国卫生研究院文献>Acta Crystallographica Section E: Crystallographic Communications >Crystal structures of {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate and {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(II)

【2h】

Crystal structures of {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate and {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(II)

机译：{μ2-NN-双（吡啶-3-基）甲基乙二酰胺}四（二甲基氨基甲硫代氨基）二嗪（II）二甲基甲酰胺的晶体结构和{μ2-NN-双（吡啶-3- （基）甲基乙二酰胺}四（二正丙基氨基甲酸二硫代氨基）二嗪（II）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The title structures, [Zn2(C3H6NS2)4(C14H14N4O2)]·2C3H7NO (I) and [Zn2(C7H14NS2)4(C₁₄H₁₄N₄O₂)] (II), each feature a bidentate, bridging bipyridyl-type ligand encompassing a di-amide group. In (I), the binuclear compound is disposed about a centre of inversion, leading to an open conformation, while in (II), the complete molecule is completed by the application of a twofold axis of symmetry so that the bridging ligand has a U-shape. In each of (I) and (II), the dithiocarbamate ligands are chelating with varying degrees of symmetry, so the zinc atom is within an NS₄ set approximating a square-pyramid for (I) and a trigonal-bipyramid for (II). The solvent dimethylformaide (DMF) molecules in (I) connect to the bridging ligand via amide-N—H⋯O(DMF) and various amide-, DMF-C—H⋯O(amide, DMF) interactions. The resultant three-molecule aggregates assemble into a three-dimensional architecture via C—H⋯π(pyridyl, chelate ring) interactions. In (II), undulating tapes sustained by amide-N—H⋯O(amide) hydrogen bonding lead to linear supramolecular chains with alternating molecules lying to either side of the tape; no further directional interactions are noted in the crystal.

机译：标题结构[Zn2（C3H6NS2）4（C14H14N4O2）]·2C3H7NO（I）和[Zn2（C7H14NS2）4（C _{14 H _{14 N _{4 O _{2 ）]（II），每个均具有双齿，桥联双吡啶基型配体，该配体包含二酰胺基。在（I）中，双核化合物位于反转中心附近，从而导致开放构象，而在（II）中，完整分子通过应用双重对称轴完成，因此桥联配体具有U -形状。在（I）和（II）的每一个中，二硫代氨基甲酸酯配体以不同的对称度螯合，因此锌原子在NS _{4 组内，近似于（I）和（A）的方锥。（II）的三角双锥体。（I）中的溶剂二甲基甲酰胺（DMF）分子通过酰胺-NH = O（DMF）和各种酰胺-，DMF-CH = O（酰胺，DMF）相互作用与桥连配体连接。所得的三分子聚集体通过CH-π（吡啶基，螯合环）相互作用组装成三维结构。在（Ⅱ）中，由酰胺-NH-OH（酰胺）氢键维持的起伏的带导致线性的超分子链，交替的分子位于带的两侧。晶体中没有发现其他定向相互作用。}}}}}

著录项

期刊名称 Acta Crystallographica Section E: Crystallographic Communications
作者
Hadi D. Arman; Pavel Poplaukhin; Edward R. T. Tiekink;
展开▼
作者单位

展开▼
年(卷),期 2017(73),Pt 10
年度 2017
页码 1501–1507
总页数 18
原文格式 PDF
正文语种
中图分类生化遗传学;生化药理学;
关键词
crystal structure zinc dithiocarbamate di-amide hydrogen bonding;

机译：晶体结构;锌;二硫代氨基甲酸酯;双酰胺;氢键;

相似文献

外文文献
中文文献
专利

1. Crystal structures of {μ2-N,N′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate and {μ2-N,N′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(II) [J] . Arman H.D., Poplaukhin P., Tiekink E.R.T. Acta Crystallographica Section E: Crystallographic Communications . 2017,第10期

机译：{μ2-N，N'-双[（吡啶-3-基）甲基]乙二酰胺}四（二甲基氨基甲硫代氨基）二嗪（II）二甲基甲酰胺的晶体结构和{μ2-N，N'-双[（吡啶-3- （基）甲基]乙二酰胺}四（二正丙基氨基甲硫代氨基）二嗪（II）
2. Crystal structures of (acetonitrile-κN)tris(pyridine-4-thioamide-κN)bis(thiocyanate-κN)cobalt(II) acetonitrile disolvate and tetrakis(pyridine-4-thioamide-κN)bis(thiocyanate-κN)nickel(II) methanol pentasolvate [J] . Neumann T., Jess I., Nther C. Acta Crystallographica Section E: Crystallographic Communications . 2018,第7期

机译：乙腈二溶剂化物（乙腈-κN）三（吡啶-4-硫酰胺-κN）双（硫氰酸酯-κN）钴（II）和四（吡啶-4-硫酰胺-κN）双（硫氰酸酯-κN）镍（II）的晶体结构戊酸五甲酯
3. Crystal structure of tetrakis[μ-2-(methoxycarbonyl)benzoato-κ2O1:O1′]bis[(N,N-dimethylformamide-κO)copper(II)](Cu—Cu) dimethylformamide disolvate [J] . Wang J., Su F., Shi L. Acta Crystallographica Section E: Crystallographic Communications . 2018,第5期

机译：四[[-2-（甲氧羰基）苯甲酸酯]-κ2O1：O1']双[（N，N-二甲基甲酰胺-κO）铜（II）]（Cu_Cu）二甲基甲酰胺的晶体结构
4. Synthesis and characterization of bis-(2-cyano-1-methyl-3-{2-{{(5-methylimidazol-4-yl)m ethyl} thio} ethyl)guanidine copper(II) sulfate tetrahydrate [C] . Sentot B Rahardjo, Teguh Endah Saraswati, Edy Pramono Joint Conference on Chemisty . 2016

机译：双 - （2-氰基-1-甲基-3- {2 - {（5-甲基咪唑-4-基）M乙基}乙基}乙基）硫酸四水合物的合成及表征
5. SOME CRYSTAL STRUCTURE STUDIES: PART I: THE CRYSTAL AND MOLECULAR STRUCTURE OF PYRACENE. PART II. THE CRYSTAL STRUCTURE OF BIS-(N-METHYL - SALICYLALDIMINATO) COPPER(II) [D] . SIMMONS, GERALD LEE. 1959

机译：某些晶体结构研究：第一部分：并苯的晶体和分子结构。第二部分双（N-甲基-水杨基亚胺基）铜的晶体结构（II）
6. Crystal structures of (acetonitrile-κN)tris(pyridine-4-thioamide-κN)bis(thiocyanate-κN)cobalt(II) acetonitrile disolvate and tetrakis(pyridine-4-thioamide-κN)bis(thiocyanate-κN)nickel(II) methanol pentasolvate [O] . Tristan Neumann, Inke Jess, Christian Näther 2018

机译：（乙腈-κN）三（吡啶-4-硫酰胺-κN）双（硫氰酸酯-κN）乙腈二溶剂化物和四（吡啶-4-硫酰胺-κN）双（硫氰酸酯-κN）镍（II）的晶体结构戊酸五甲酯
7. Crystal structures of {μ2-N,N′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate and {μ2-N,N′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(II) [O] . Hadi D. Arman, Pavel Poplaukhin, Edward R. T. Tiekink 2017

机译：{μ2-N，N'-双[（吡啶-3-基）甲基]乙二酰胺}四（二甲基二硫代甲酸酯）二嗪（II）二甲基甲酰胺的晶体结构解离和{μ2-N，N'-双[（吡啶-3-）和l）甲基]乙二胺}四（二正丙基二硫代甲酸）二嗪（II）
8. Novel Square Pyramidal Copper(II) Complexes of the Stereospecific Linear NSNNTetradentate Ligand N-((2-Pyridyl)methyl)-2-((2-Aminoethyl)thio) Acetamide (pygeH). The Crystal Structures of (Cu(pyge)X) (X = Br, N3) [R] . Toscano, P. J., Fordon, K. J., Macherone, D., 1990

机译：新型方形金字塔形铜（II）配合物的立体特异性线性NsNN四齿配体N - （（2-吡啶基）甲基）-2 - （（2-氨基乙基）硫代）乙酰胺（pygeH）。（Cu（pyge）X）（X = Br，N3）的晶体结构

Crystal structures of {μ2-NN′-bis­(pyridin-3-yl)meth­ylethanedi­amide}tetra­kis­(di­methyl­carbamodi­thio­ato)dizinc(II) di­methyl­formamide disolvate and {μ2-NN′-bis­(pyridin-3-yl)meth­ylethanedi­amide}tetra­kis­(di-n-propyl­carbamodi­thio­ato)dizinc(II)

摘要

著录项

相似文献

相关主题

期刊订阅

Crystal structures of {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate and {μ2-NN′-bis(pyridin-3-yl)methylethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(II)